Traws Pharma, Inc. Common Stock
Symbol: TRAW (NASDAQ)
1.81
▼ (-3.21%) -0.060
Company Description:
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
Key Stats
- Today's Open: $1.835
- Today's High: $1.899
- Today's Low: $1.79
- Today's Volume: 41.68K
- Yesterday Close: $1.87
- Yesterday High: $1.99
- Yesterday Low: $1.73
- Yesterday Volume: 164.05K
- Last Min Volume: 1
- Last Min High: $1.81
- Last Min Low: $1.81
- Last Min VWAP: $1.81
Company Profile
- Name: Traws Pharma, Inc. Common Stock
- Website: https://www.trawspharma.com
- Listed Date: 2013-07-25
- Location: NEWTOWN, PA
- Market Status: Active
- CIK Number: 0001130598
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $13.14M
- Round Lot: 100
- Outstanding Shares: 7.06M
- Asset Type: CS
RECENT FILINGS FOR TRAW
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-18 | 8-K | View |
| 2025-08-14 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-03 | 8-K | View |
| 2025-06-30 | 8-K | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-03 | 8-K | View |
| 2025-05-27 | 8-K | View |
| 2025-05-19 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-15 | 8-K | View |
| 2025-05-12 | SCHEDULE 13G | View |
| 2025-04-30 | 10-K/A | View |
| 2025-04-18 | 8-K | View |
| 2025-04-08 | 4 | View |
Latest News on TRAW